Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Nov;70(3):481–490. doi: 10.1111/j.1476-5381.1980.tb08727.x

Comparison of the binding characteristics of tritiated opiates and opioid peptides.

M G Gillan, H W Kosterlitz, S J Paterson
PMCID: PMC2044355  PMID: 7437652

Abstract

1 Binding assays on homogenates of guinea-pig brain showed that the maximal number of binding sites was different tritiated ligands interacting with the opiate receptors. 2 At 25 degrees C the binding capacity of morphine or dihydromorphine was only about 3 pmol/g fresh brain whereas etorphine and D-Ala2-L-Leu5- and D-Ala2-L-Met5-enkephalin amide had capacities of 13 to 15 pmol/g brain. D-Ala2-D-Leu5-enkephalin had an intermediate capacity of about 6 pmol/g brain. 3 The binding capacities of the natural methionine- and leucine-enkephalins measured at 0 degrees C were 5 to 6 pmol/g brain. At this temperature, the binding capacity of dihydromorphine, D-Ala2-D-Leu5-enkephalin and of the two enkephalin amides was only slightly lower than at 25 degrees C. 4 In assays in which unlabelled ligand competed with the same labelled ligand, the inhibition constants (KI) were equal to or not more than twice as large as the equilibrium dissociation constant (KD) determined in saturation assays. In contrast, the KI of unlabelled dihydromorphine against [3H]-D-Ala2-D-Leu5-enkephalin or of unlabelled D-Ala2-D-Leu5-enkephalin against [3H]-dihydromorphine was about 20 times higher than the respective KD values. 5 When for a given compound the ratio of the KI value against [3H]-D-Ala2-D-Leu5-enkephalin to the KI value against [3H]-dihydromorphine (discrimination ratio) is calculated, a high value indicates selectivity in favour of the mu-receptor and a low value selectivity in favour of the delta-receptor. The most selective mu-agonist known so far is normorphine with a discrimination ratio of 70 and the most selective delta-agonist is D-Ala2-D-Leu5-enkephalin with a ratio of 0.11. The selectivity of the known antagonists is in favour of the mu-receptor, since their discrimination ratios are larger than 1, varying between 10 for naloxone and 4 for Mr 2266.

Full text

PDF
481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang K. J., Cooper B. R., Hazum E., Cuatrecasas P. Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. Mol Pharmacol. 1979 Jul;16(1):91–104. [PubMed] [Google Scholar]
  2. Chang K. J., Cuatrecasas P. Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity. J Biol Chem. 1979 Apr 25;254(8):2610–2618. [PubMed] [Google Scholar]
  3. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  4. Childers S. R., Creese I., Snowman A. M., Synder S. H. Opiate receptor binding affected differentially by opiates and opioid peptides. Eur J Pharmacol. 1979 Apr 1;55(1):11–18. doi: 10.1016/0014-2999(79)90142-0. [DOI] [PubMed] [Google Scholar]
  5. Gilbert P. E., Martin W. R. The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976 Jul;198(1):66–82. [PubMed] [Google Scholar]
  6. Gillan M. G., Kosterlitz H. W., Paterson S. J. Comparison of the binding characteristics of tritiated opiates and opioid peptides [proceedings]. Br J Pharmacol. 1979 May;66(1):86P–87P. [PMC free article] [PubMed] [Google Scholar]
  7. Hancock A. A., DeLean A. L., Lefkowitz R. J. Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique. Mol Pharmacol. 1979 Jul;16(1):1–9. [PubMed] [Google Scholar]
  8. Hutchinson M., Kosterlitz H. W., Leslie F. M., Waterfield A. A. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br J Pharmacol. 1975 Dec;55(4):541–546. doi: 10.1111/j.1476-5381.1975.tb07430.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kosterlitz H. W., Lord J. A., Paterson S. J., Waterfield A. A. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors. Br J Pharmacol. 1980 Feb;68(2):333–342. doi: 10.1111/j.1476-5381.1980.tb10422.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Law P. Y., Loh H. H. 3H-Leu5-enkephalin specific binding to synaptic membrane-comparison with 3H-dihydromorphine and 3H-naloxone. Res Commun Chem Pathol Pharmacol. 1978 Sep;21(3):409–434. [PubMed] [Google Scholar]
  11. Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 1977 Jun 9;267(5611):495–499. doi: 10.1038/267495a0. [DOI] [PubMed] [Google Scholar]
  12. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976 Jun;197(3):517–532. [PubMed] [Google Scholar]
  13. Meunier J. C., Moisand C. Binding of Leu5-enkephalin and Met5-enkephalin to a particulate fraction from rat cerebrum. FEBS Lett. 1977 May 15;77(2):209–213. doi: 10.1016/0014-5793(77)80236-6. [DOI] [PubMed] [Google Scholar]
  14. Miller R. J., Chang K. J., Leighton J., Cuatrecasas P. Interaction of iodinated enkephalin analogues with opiate receptors. Life Sci. 1978 Feb;22(5):379–388. doi: 10.1016/0024-3205(78)90284-9. [DOI] [PubMed] [Google Scholar]
  15. Pasternak G. W., Snyder S. H. Identification of novel high affinity opiate receptor binding in rat brain. Nature. 1975 Feb 13;253(5492):563–565. doi: 10.1038/253563a0. [DOI] [PubMed] [Google Scholar]
  16. Robson L. E., Kosterlitz H. W. Specific protection of the binding sites of D-Ala2-D-Leu5-enkephalin (delta-receptors) and dihydromorphine (mu-receptors). Proc R Soc Lond B Biol Sci. 1979 Aug 31;205(1160):425–432. doi: 10.1098/rspb.1979.0076. [DOI] [PubMed] [Google Scholar]
  17. Simantov R., Childers S. R., Snyder S. H. The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide. Eur J Pharmacol. 1978 Feb 1;47(3):319–331. doi: 10.1016/0014-2999(78)90240-6. [DOI] [PubMed] [Google Scholar]
  18. Simon E. J., Hiller J. M., Edelman I. Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci U S A. 1973 Jul;70(7):1947–1949. doi: 10.1073/pnas.70.7.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Simon E. J., Hiller J. M., Groth J., Edelman I. Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect. J Pharmacol Exp Ther. 1975 Mar;192(3):531–537. [PubMed] [Google Scholar]
  20. Wong D. T., Horng J. S. Stereospecific interaction of opiate narcotics in binding of 3H-dihydromorphine to membranes of rat brain. Life Sci. 1973 Dec 1;13(11):1543–1556. doi: 10.1016/0024-3205(73)90143-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES